Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T01:36:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with minimal navigation. The prior detailed study content and metadata have been removed, indicating an error state rather than an update to the study data.
    Difference
    20%
    Check dated 2026-09-20T00:22:51.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a CMS/content update. This change does not modify the study details or related information.
    Difference
    0.1%
    Check dated 2026-08-29T20:52:58.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now includes posted results and related outcomes, biomarker analyses, and access to the protocol and statistical analysis plan, reflecting the updated results status of the trial.
    Difference
    2%
    Check dated 2026-08-22T20:43:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added. A large block of non-core footer and indexing terms was removed from the page, simplifying the display without changing the core study details.
    Difference
    18%
    Check dated 2026-08-08T18:14:26.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was applied to the page. This is a back-end update and does not modify the study information, eligibility criteria, or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:33:26.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.